CompoAtlas

Doctor's Choice Multivitamins - Men

Natural health product licensed in Canada

Licence holder
Nature's Way of Canada Ltd/ Enzymatic Therapy (Canada) Inc
NPN or DIN-HM
80050234
Status
Inactive licence
Licence date
15 April 2014
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Lycopène tout trans0.67 mgNot calculated
1,2,3,5/4,6- hexahydroxycyclohexane10 mgNot calculated
Iode

Source : Iodure de potassium

100 mcg300 µg
(3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol

Source : Lutéine(USP)

0.5 mgNot calculated
3-Pyridinecarboxamide

Source : Niacine

30 mgNot calculated
3-Pyridinecarboxamide

Source : Niacinamide

30 mgNot calculated
Manganèse

Source : Citrate de manganèse (II)

0.67 mg2,010 µg
Molybdène

Source : Molybdate de sodium

25 mcg75 µg
Spinacia

Source : Spinacia oleracea - feuille

1.07 mgNot calculated
Camellia sinensis

Source : Camellia sinensis - feuille

Extraction ratio : 3:1

Dry plant equivalent : 30 mg

Potency : 2.5 mg Epigallocatechin 3-gallate

10 mgNot calculated
Camellia sinensis

Source : Camellia sinensis - feuille

Potency : 1 mg Caffeine

Not specifiedNot calculated
Magnésium

Source : Aspartate de magnésium

50 mg150,000 µg
Magnésium

Source : Oxyde de magnésium

50 mg150,000 µg
Solanum lycopersicum

Source : Solanum lycopersicum - fruit

2.14 mgNot calculated
Vaccinium myrtillus

Source : Vaccinium myrtillus - Fruit

Extraction ratio : 4:1

Dry plant equivalent : 13.32 mg

3.33 mgNot calculated
Vitamine D

Source : Cholécalciférol

Potency : 266.67 UI

6.67 mcg20.01 µg
Brassica Oleracea Italica (broccoli) Extract

Source : Fleur

2.14 mgNot calculated
Brassica oleracea var. acephala

Source : Brassica oleracea var. viridis - feuille

3.21 mgNot calculated
Panax ginseng

Source : Panax ginseng - racine

Potency : 7 % Ginsenosides

5 mgNot calculated
Biotine200 mcg600 µg
Brassica oleracea var. capitata

Source : Brassica oleracea var. capitata - feuille

2.14 mgNot calculated
Acide D-pantothénique

Source : D-Pantothénate de calcium

20 mgNot calculated
Cuivre

Source : Gluconate cuivrique

0.67 mg2,010 µg
Prunus avium

Source : Prunus avium - fruit

Extraction ratio : 10:1

Dry plant equivalent : 166.7 mg

16.67 mgNot calculated

Non-medicinal ingredients

Acide stéarique, Eau purifiée, Maltodextrine, Macrogol, acacia, cellulose, Dioxyde de silicium, Stéarate de magnésium, Croscarmellose de sodium, Hypromellose

PopulationAgeQuantity per servingFrequency
Adultes de sexe masculinNot specified3 Comprimé1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Multi-Vitamin/Mineral supplement. A factor in the maintenance of good health. Provides antioxidants Helps to form red blood cells. Helps in the function of the thyroid gland. Provides support for healthy glucose metabolism. Helps to maintain immune function. Helps the body to metabolize carbohydrates, fats and proteins. Helps maintain healthy calcium metabolism.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80050234

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vaccinium myrtillus
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

  • Vitamine D
    Read the warning, when it applies and the studies cited

    VITAMIN D (>1,000 - 2,500 IU)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.

    Applies to products containing vitamin K2.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: All products.

    Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products containing zinc sourced from picolinate.

    Do not use if you are pregnant or breastfeeding (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing more than 350 mg of magnesium per day.

    When using this product you may experience diarrhea (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 June 2026

  • Panax ginseng
    Read the warning, when it applies and the studies cited

    PANAX GINSENG

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Vuksan et al. 2008; Seely et al. 2008; Sievenpiper et al. 2006; ESCOP 2003; Tetsutani et al. 2000; Sotaniemi et al. 1995; Chin 1991).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, blood thinners or digoxin (Brinker 2010; Lee et al. 2008a; Dasgupta and Reyes 2005; Janetzki and Morreale 1997; Gonzalez-Seijo et al. 1995; Shader and Greenblatt 1988; Jones and Runikis 1987; Shader and Greenblatt 1985).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use in cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency (Bensky et al. 2004).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience insomnia, anxiety or headaches (Lee et al. 2008b; Vuksan et al 2008; de Andrade et al.2007; Sievenpiper et al. 2006; Coon and Ernst 2002; Ellis and Reddy 2002; Scaglione et al. 2001; Siegel 1979).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 27 June 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line